Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cyclerion Therapeutics (CYCN) Asset Utilization Ratio (2019 - 2025)

Cyclerion Therapeutics has reported Asset Utilization Ratio over the past 7 years, most recently at 0.29 for Q3 2025.

  • Quarterly results put Asset Utilization Ratio at 0.29 for Q3 2025, up 1310.51% from a year ago — trailing twelve months through Sep 2025 was 0.29 (up 1310.51% YoY), and the annual figure for FY2024 was 0.17, changed.
  • Asset Utilization Ratio for Q3 2025 was 0.29 at Cyclerion Therapeutics, up from 0.23 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for CYCN hit a ceiling of 0.29 in Q3 2025 and a floor of 0.01 in Q1 2021.
  • Median Asset Utilization Ratio over the past 5 years was 0.05 (2021), compared with a mean of 0.1.
  • Biggest five-year swings in Asset Utilization Ratio: plummeted 76.12% in 2023 and later skyrocketed 1310.51% in 2025.
  • Cyclerion Therapeutics' Asset Utilization Ratio stood at 0.06 in 2021, then fell by 24.01% to 0.05 in 2022, then crashed by 56.06% to 0.02 in 2023, then soared by 944.98% to 0.22 in 2024, then skyrocketed by 33.28% to 0.29 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.29 (Q3 2025), 0.23 (Q2 2025), and 0.21 (Q1 2025) per Business Quant data.